Lomitapide

Lojuxta 10 MG Capsulas Duras

10 mg cápsula duraSpainMarketedAuthorised 29 Jun 2014

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lomitapide

Lojuxta 10 MG Capsulas Duras

10 mg cápsula duraSpainMarketedAuthorised 29 Jun 2014

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Lojuxta 20 mg harde capsulesNetherlands · Capsule, hard · Chiesi Farmaceutici S.p.A.

LojuxtaSaudi Arabia · Catalent

JuxtapidCanada · 20 MG · Capsule · Chiesi Farmaceutici S.P.A.

JuxtapidCanada · 5 MG · Capsule · Chiesi Farmaceutici S.P.A.

JuxtapidCanada · 10 MG · Capsule · Chiesi Farmaceutici S.P.A.

JuxtapidUnited States · 10MG BASE, 20MG BASE, 2MG BASE … · capsule · Chiesi

Juxtapid capsule 5mgTaiwan · 膠囊劑 · 台灣安捷隆股份有限公司

Packs

Pack	Code	Status
LOJUXTA 10 MG CAPSULAS DURAS 28 CAPSULAS	702786

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lomitapide
Strength: 10 mg
Dosage form: cápsula dura
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 29 Jun 2014
Registration: 113851002
Marketing authorisation holder: Chiesi Farmaceutici S.P.A.
Procedure: EU centralised
Supply: Diagnóstico Hospitalario

Lojuxta 2 MG Capsulas DurasLomitapide · 2,28 mg · cápsula duraSpain